Global Pharmaceutical Excipients Market
Published Date:5 Feb 2020
Category:Healthcare & Pharmaceuticals
Impact Analysis on the Growth of Market
Activating Probable Propositions Amidst COVID-19 Crisis
With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More
Excipients are additives substances used in the tablet formulation to improve bulkiness, disintegration, dissolution rate and bioavailability of the drug. Excipients are crucial to drug delivery within the body. It does not have any medicinal properties. Its standard purpose is to streamline the manufacture of the drug and ultimately enhance the physiological absorption of the drug. Excipients might aid lubricity, flowability, disintegration, taste, and may confer some anti-microbial function to the active pharmaceutical agent.
Rapid advances in drug discovery and healthcare industry provide impetus to the pharmaceutical excipients market. Moreover, the growth of oral drugs in recent times, and increase in penetration and accessibility to drugs in the emerging markets has led to an expansion of the pharmaceutical market, and thereby the excipients market.
The market for pharmaceutical excipients has seen strong growth over the past few years and is forecast to expand at a compound annual growth rate of 6.1% from 2016 to 2021, in hand with the rising demand in the pharmaceutical industry for functional excipients. By 2021, the pharmaceutical excipients market will be worth an estimated $8.1 billion.
The demand for excipients will see an upward trend in the coming years due to the increase in demand for generics, as the patents of a number of blockbuster drugs are set to expire. The emergence of new excipients is also boosting the market. Nanotechnology helps impart new functions to pharmaceutical excipients. Products such as nanotechnology-enabled drug delivery systems and liposomal drug delivery systems enable better targeting to the disease site, and thus reducing the drug toxicity.
Aging population base, growing expenditure on healthcare, increasing healthcare penetration in developing countries, are some of the drivers of the pharmaceutical industry, which will, in turn, raise the demand for pharmaceutical excipients. The challenge in this sector is the increasing stringency of regulatory requirements and the high-quality standards that are to be maintained, as the lives of the people is at stake.
The market for pharmaceutical excipients can be segmented based on functionality such as diluents or fillers, binders or adhesives, disintegrants, lubricants, gladiant, flavors, color, and sweeteners. The excipients can also be segmented based on delivery mode - oral formulation, tablets, capsules, gelatin, liquid formulation, advanced delivery systems.
North America accounts for the largest share of the global pharmaceutical excipients market, followed by Europe, Asia-Pacific, and the rest of the world. In future, stronger growth is expected to be witnessed in Asia, particularly in India and China. Low labour costs has driven outsourcing to these locations and have turned to be lucrative markets for manufacturing of generic drugs.
ADM, Ashland, BASF, Evonik, Dow Chemical
Report ContentsRegional AnalysisReport Highlights
Market Drivers, Restraints and Opportunities
Pharmaceutical Excipients Market Size & Forecast 2016 to 2022
Supply & Demand Value Chain
Market - Current Trends
Competition & Major Companies
Technology and R&D Status
Porters Five Force Analysis
Strategic and Critical Success Factor Analysis of Key Players
US and Canada
Mexico, Brazil, Argentina and Rest of Latin America
EU5 (Germany, France, Italy, Spain, U.K.)
Nordic Countries (Denmark, Finland, Norway, and Sweden)
Benelux (Belgium, The Netherlands, and Luxembourg)
Rest of Western Europe
Rest of Eastern Europe
Australia and New Zealand
Rest of Asia Pacific
Middle East and Africa
GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
Consumer and Pricing Analysis
Market dynamics of the industry
Estimated Market Sizing in terms of volume and value
Recent trends in Market and impact
Research Status and Technology Overview
Extensive Industry Structure Coverage